Get started
Author

Beth Rumberger

Observed names: B. Rumberger, B.E. Rumberger, Beth E. Rumberger, Rumberger, Beth
Observed institution: Incyte (United States)
ORCID: 0000-0002-0614-5230
Observed ORCID: 0000-0002-0614-5230
OpenAlex ID: A5020347975
Transcriptomic analysis of hidradenitis suppurativa skin suggests roles for multiple inflammatory pathways in disease pathogenesis
2020 · Beth E. Rumberger, Erika L. Boarder, et al. · Inflammation Research · 47
INCB040093 Is a Novel PI3Kδ Inhibitor for the Treatment of B Cell Lymphoid Malignancies
2017 · Niu Shin, Yun-Long Li, et al. · Journal of Pharmacology and Experimental Therapeutics · 24
PDF
Modeling Skin Inflammation Using Human In Vitro Models
2021 · Erika Boarder, Beth Rumberger, et al. · Current Protocols · 13
Baseline Levels of Circulating Inflammatory Biomarkers Stratify Patients with Vitiligo Who Significantly Repigment after Treatment with Ruxolitinib Cream
2023 · Michael D. Howell, Fiona I. Kuo, et al. · JID Innovations · 9
PDF
CD19 expression is preserved following CD19-directed monoclonal antibody therapy with tafasitamab
2025 · Johannes Duell, Diana Alvarez Arias, et al. · Blood · 2
PDF
Maintenance of CD19 Expression after Tafasitamab Treatment in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) from Clinical Trial and Real-World Settings
2024 · Johannes Duell, Diana Alvarez Arias, et al. · Blood · 2
PDF
CD19 expression in diffuse large B-cell lymphoma (DLBCL) patient biopsies after treatment with tafasitamab.
2024 · Alla Volgina, Beth Rumberger, et al. · Journal of Clinical Oncology · 2
27568 Maintenance of repigmentation after discontinuation of ruxolitinib cream in patients with vitiligo
2021 · David Rosmarin, Amit G. Pandya, et al. · Journal of the American Academy of Dermatology · 2
Abstract 692: The BET inhibitor INCB054329 is synergistic with JAK1 inhibition in models of multiple myeloma
2015 · Matthew C. Stubbs, Xuesong M. Liu, et al. · Cancer Research · 2
Maintenance of CD19 Expression after Tafasitamab Treatment in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) from Clinical Trial and Real-World Settings
2025 · Johannes Duell, Diana Alvarez Arias, et al. · Transplantation and Cellular Therapy · 1
303 Maintenance of Repigmentation After Discontinuation of Ruxolitinib Cream in Patients With Vitiligo
2021 · D. Rosmarin, A.G. Pandya, et al. · Journal of Investigative Dermatology · 1
PDF
Abstract 779: Blockade of the IL-6/JAK/STAT3 signaling pathway inhibits pancreatic tumor cell growth in 3D spheroid cultures and in xenograft models
2015 · Jun Li, Eian Caulder, et al. · Cancer Research · 1
Cd19 Expression Persists in Diffuse Large B-cell Lymphoma Patient Biopsies After Treatment With Tafasitamab
2024 · Volgina, Anna, Rumberger, Beth, et al. · University of Southern Denmark Research Portal (University of Southern Denmark)
Janus Kinase (JAK) 1 Inhibition Results in Significant Changes in Serum Proteins and Peripheral T-Cell Populations That Correlate with Clinical Scores in Patients with Chronic Graft Versus Host Disease (GVHD): An Analysis from Gravitas-309
2024 · Michael Pratta, Angelina Volkova, et al. · Transplantation and Cellular Therapy
Janus Kinase (JAK) 1 Inhibition Results in Significant Changes in Serum Proteins and Peripheral T-Cell Populations That Correlated with Clinical Scores in Chronic Graft Versus Host Disease (GVHD) Patients (an Analysis from GRAVITAS-309)
2023 · Michael Pratta, Angelina Volkova, et al. · Blood
PDF
349 Hidradenitis Suppurativa Lesions are Characterized by Increased Kinase Signaling Activity
2019 · B.E. Rumberger, E.L. Boarder, et al. · Journal of Investigative Dermatology
351 Inhibitory Activity of Janus Kinase Inhibitors in Keratinocyte Cultures
2019 · E.L. Boarder, B.E. Rumberger, et al. · Journal of Investigative Dermatology
157 Ruxolitinib Cream significantly modulates inflammatory profiles of Patients with Vitiligo
2019 · S. Owens, B.E. Rumberger, et al. · Journal of Investigative Dermatology
Works count: 18
Citation count: 106
H-index: 4
I10-index: 3
Year
Topic
Type